| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Thye Dirk | CEO and CMO, Director | C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO | /s/ Dirk Thye | 20 Jun 2025 | 0001638945 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QNCX | Common Shares | Award | $181,133 | +150,944 | +18% | $1.20 | 994,885 | 18 Jun 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QNCX | Warrants | Award | $18,868 | +150,944 | $0.1250 | 150,944 | 18 Jun 2025 | Common Shares | 150,944 | $1.20 | Direct |